- Home
- MLGO vs IBIO Comparison
MLGO vs IBIO Comparison
Compare MLGO & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- IBIO
- Stock Information
- Founded
- MLGO 2018
- IBIO 2008
- Country
- MLGO China
- IBIO United States
- Employees
- MLGO N/A
- IBIO N/A
- Industry
- MLGO EDP Services
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- IBIO Health Care
- Exchange
- MLGO Nasdaq
- IBIO Nasdaq
- Market Cap
- MLGO 15.6M
- IBIO 15.9M
- IPO Year
- MLGO N/A
- IBIO N/A
- Fundamental
- Price
- MLGO $0.61
- IBIO $0.78
- Analyst Decision
- MLGO
- IBIO Strong Buy
- Analyst Count
- MLGO 0
- IBIO 3
- Target Price
- MLGO N/A
- IBIO $4.87
- AVG Volume (30 Days)
- MLGO 39.9M
- IBIO 5.4M
- Earning Date
- MLGO 04-28-2025
- IBIO 05-02-2025
- Dividend Yield
- MLGO N/A
- IBIO N/A
- EPS Growth
- MLGO N/A
- IBIO N/A
- EPS
- MLGO 0.55
- IBIO N/A
- Revenue
- MLGO $74,185,505.00
- IBIO $375,000.00
- Revenue This Year
- MLGO N/A
- IBIO $36.00
- Revenue Next Year
- MLGO N/A
- IBIO N/A
- P/E Ratio
- MLGO $1.25
- IBIO N/A
- Revenue Growth
- MLGO N/A
- IBIO 650.00
- 52 Week Low
- MLGO $0.50
- IBIO $0.64
- 52 Week High
- MLGO $185.20
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- MLGO 33.92
- IBIO 44.74
- Support Level
- MLGO $0.50
- IBIO $0.71
- Resistance Level
- MLGO $0.75
- IBIO $0.81
- Average True Range (ATR)
- MLGO 0.11
- IBIO 0.10
- MACD
- MLGO 0.15
- IBIO 0.01
- Stochastic Oscillator
- MLGO 36.39
- IBIO 29.06
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.